HEADER TRANSFERASE 28-JAN-16 5HV8 TITLE SOLUTION STRUCTURE OF AN OCTANOYL- LOADED ACYL CARRIER PROTEIN DOMAIN TITLE 2 FROM MODULE MLSA2 OF THE MYCOLACTONE POLYKETIDE SYNTHASE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYPE I MODULAR POLYKETIDE SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM ULCERANS; SOURCE 3 ORGANISM_TAXID: 1809; SOURCE 4 GENE: MLSA2, MUP039C; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: TUNER; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28 KEYWDS ACYL CARRIER PROTEIN MYCOLACTONE, TRANSFERASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.VANCE,O.TKACHENKO,B.THOMAS,M.BASSUNI,H.HONG,D.NIETLISPACH, AUTHOR 2 R.W.BROADHURST REVDAT 6 23-OCT-19 5HV8 1 REMARK REVDAT 5 08-MAY-19 5HV8 1 REMARK REVDAT 4 17-JAN-18 5HV8 1 TITLE REVDAT 3 20-APR-16 5HV8 1 JRNL REVDAT 2 30-MAR-16 5HV8 1 JRNL REVDAT 1 09-MAR-16 5HV8 0 JRNL AUTH S.VANCE,O.TKACHENKO,B.THOMAS,M.BASSUNI,H.HONG,D.NIETLISPACH, JRNL AUTH 2 W.BROADHURST JRNL TITL STICKY SWINGING ARM DYNAMICS: STUDIES OF AN ACYL CARRIER JRNL TITL 2 PROTEIN DOMAIN FROM THE MYCOLACTONE POLYKETIDE SYNTHASE. JRNL REF BIOCHEM.J. V. 473 1097 2016 JRNL REFN ESSN 1470-8728 JRNL PMID 26920023 JRNL DOI 10.1042/BCJ20160041 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.3 REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES WERE CALCULATED WITH NO REMARK 3 HYDROGEN BOND RESTRAINTS, AND 167 DIHEDRAL ANGLE RESTRAINTS REMARK 3 DETERMINED USING DANGLE REMARK 4 REMARK 4 5HV8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000217755. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 150 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 150 MM SODIUM PHOSPHATE, 0.1 MM REMARK 210 3,3,3-TRIMETHYLSILYLPROPIONATE, REMARK 210 SODIUM SALT, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D 15N-HSQC REMARK 210 -TOCSY; 3D 15N-HSQC-NOESY; 3D REMARK 210 HNCA; 3D HN(CO)CA; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D HCCH-TOCSY; 3D REMARK 210 13C-HSQC-NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR ANALYSIS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A2047 91.53 52.62 REMARK 500 1 HIS A2048 22.54 -74.04 REMARK 500 1 HIS A2078 135.48 69.21 REMARK 500 1 ASP A2095 -162.06 -107.00 REMARK 500 1 LEU A2112 -169.78 -109.88 REMARK 500 2 HIS A2077 -8.04 -172.35 REMARK 500 2 LEU A2112 -170.29 -66.67 REMARK 500 2 THR A2124 147.29 -177.75 REMARK 500 3 HIS A2077 -3.65 -173.95 REMARK 500 3 ASP A2095 -169.49 -115.15 REMARK 500 3 THR A2124 146.39 -177.62 REMARK 500 4 LEU A2051 27.68 -77.06 REMARK 500 4 ASN A2052 150.02 -39.86 REMARK 500 4 HIS A2077 3.37 -173.38 REMARK 500 4 ASP A2095 -169.67 -103.42 REMARK 500 4 THR A2124 142.22 -177.95 REMARK 500 5 SER A2047 55.39 -116.29 REMARK 500 5 HIS A2048 23.60 -74.32 REMARK 500 5 MET A2049 -74.35 -40.09 REMARK 500 5 HIS A2077 -3.03 -169.32 REMARK 500 5 ASP A2095 -164.18 -105.89 REMARK 500 5 THR A2124 144.88 -177.21 REMARK 500 5 SER A2139 83.77 54.34 REMARK 500 6 MET A2049 -84.43 -106.25 REMARK 500 6 ARG A2050 -60.59 -121.83 REMARK 500 6 ASN A2052 151.14 -38.22 REMARK 500 6 HIS A2077 55.41 -155.00 REMARK 500 6 THR A2124 143.97 -177.71 REMARK 500 6 SER A2139 -157.95 61.69 REMARK 500 7 ILE A2083 97.48 -67.93 REMARK 500 7 ASP A2095 -166.84 -103.91 REMARK 500 7 LEU A2118 -70.41 -40.30 REMARK 500 7 SER A2139 -160.92 65.12 REMARK 500 8 MET A2049 22.67 -76.30 REMARK 500 8 HIS A2077 -4.90 -169.51 REMARK 500 8 THR A2124 142.58 -177.63 REMARK 500 9 HIS A2048 23.17 -70.98 REMARK 500 9 LEU A2051 -64.61 -138.74 REMARK 500 9 ASP A2095 -164.20 -112.31 REMARK 500 9 THR A2124 146.27 -177.02 REMARK 500 9 SER A2139 -160.88 53.46 REMARK 500 10 MET A2049 -71.61 -68.75 REMARK 500 10 ARG A2050 -65.47 -95.93 REMARK 500 10 LEU A2051 -57.05 -136.92 REMARK 500 10 THR A2124 142.63 -178.17 REMARK 500 10 SER A2139 -174.30 68.70 REMARK 500 11 HIS A2048 23.69 -79.52 REMARK 500 11 HIS A2078 79.62 37.89 REMARK 500 11 ASP A2095 -165.87 -110.99 REMARK 500 11 THR A2124 138.39 -177.70 REMARK 500 REMARK 500 THIS ENTRY HAS 90 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG A 2050 LEU A 2051 9 144.17 REMARK 500 ARG A 2050 LEU A 2051 10 147.23 REMARK 500 ASN A 2052 GLY A 2053 10 149.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 66S A 2201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30006 RELATED DB: BMRB DBREF 5HV8 A 2050 2140 UNP Q6MZA5 Q6MZA5_MYCUA 2050 2140 SEQADV 5HV8 GLY A 2046 UNP Q6MZA5 EXPRESSION TAG SEQADV 5HV8 SER A 2047 UNP Q6MZA5 EXPRESSION TAG SEQADV 5HV8 HIS A 2048 UNP Q6MZA5 EXPRESSION TAG SEQADV 5HV8 MET A 2049 UNP Q6MZA5 EXPRESSION TAG SEQRES 1 A 95 GLY SER HIS MET ARG LEU ASN GLY LEU SER PRO GLN GLN SEQRES 2 A 95 GLN GLN GLN THR LEU ALA THR LEU VAL ALA ALA ALA THR SEQRES 3 A 95 ALA THR VAL LEU GLY HIS HIS THR PRO GLU SER ILE SER SEQRES 4 A 95 PRO ALA THR ALA PHE LYS ASP LEU GLY ILE ASP SER LEU SEQRES 5 A 95 THR ALA LEU GLU LEU ARG ASN THR LEU THR HIS ASN THR SEQRES 6 A 95 GLY LEU ASP LEU PRO PRO THR LEU ILE PHE ASP HIS PRO SEQRES 7 A 95 THR PRO HIS ALA LEU THR GLN HIS LEU HIS THR ARG LEU SEQRES 8 A 95 THR GLN SER HIS HET 66S A2201 65 HETNAM 66S S-[2-({N-[(2R)-2-HYDROXY-3,3-DIMETHYL-4-(PHOSPHONOOXY) HETNAM 2 66S BUTANOYL]-BETA-ALANYL}AMINO)ETHYL] OCTANETHIOATE FORMUL 2 66S C19 H37 N2 O8 P S HELIX 1 AA1 HIS A 2048 ASN A 2052 5 5 HELIX 2 AA2 SER A 2055 LEU A 2075 1 21 HELIX 3 AA3 THR A 2079 ILE A 2083 5 5 HELIX 4 AA4 ALA A 2088 GLY A 2093 1 6 HELIX 5 AA5 ASP A 2095 ASN A 2109 1 15 HELIX 6 AA6 THR A 2117 HIS A 2122 1 6 HELIX 7 AA7 THR A 2124 GLN A 2138 1 15 LINK OG SER A2096 P24 66S A2201 1555 1555 1.58 SITE 1 AC1 5 ILE A2094 ASP A2095 SER A2096 LEU A2097 SITE 2 AC1 5 PHE A2120 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.001000 0.000000 0.000000 0.00000 SCALE2 0.000000 0.001000 0.000000 0.00000 SCALE3 0.000000 0.000000 0.001000 0.00000 MODEL 1